Chemoinformaics analysis of POTASSIUM;2-HYDROXY-2-OXOACETATE
Molecular Weight | 128.124 | nRot | 0 |
Heavy Atom Molecular Weight | 127.116 | nRig | 9 |
Exact Molecular Weight | 127.951 | nRing | 0 |
Solubility: LogS | -3.388 | nHRing | 0 |
Solubility: LogP | 3.263 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 8 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 1 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 50.2748 |
nHD | 1 | BPOL | 3.60721 |
QED | 0.603 |
Synth | 4.086 |
Natural Product Likeliness | 2.33 |
NR-PPAR-gamma | 0.28 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.064 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.552 |
MDCK | 0.0000236 |
BBB | 0.798 |
PPB | 0.841726 |
VDSS | 1.149 |
FU | 0.379005 |
CYP1A2-inh | 0.103 |
CYP1A2-sub | 0.15 |
CYP2c19-inh | 0.055 |
CYP2c19-sub | 0.904 |
CYP2c9-inh | 0.108 |
CYP2c9-sub | 0.754 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.594 |
CYP3a4-inh | 0.11 |
CYP3a4-sub | 0.245 |
CL | 6.063 |
T12 | 0.243 |
hERG | 0.013 |
Ames | 0.009 |
ROA | 0.017 |
SkinSen | 0.795 |
Carcinogencity | 0.128 |
EI | 0.965 |
Respiratory | 0.33 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.708037 |